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LETTER TO THE EDITOR
Gianotti-Crosti Syndrome Following Novel Influenza 
A (H1N1) Vaccination
Na Hyun Kwon, M.D., Jung Eun Kim, M.D., Baik Kee Cho, M.D., Hyun Jeong Park, M.D.
Department of Dermatology, St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
Dear Editor:
Gianotti-Crosti syndrome (GCS) is a self-limited, papulove-
sicular exanthem with a symmetrical distribution on the 
hands, feet and faces of children between 2 and 6 years. 
GCS is usually associated with viral infections or immuni-
zation, but the pathogenesis remains controversial
1.
A 7-year-old boy presented with a 2-day history of asymp-
tomatic symmetrical monomorphic papules of the face 
and extensor surfaces of the extremities (Fig. 1). The le-
sions had appeared 5 days after a single 15-μg dose of a 
novel influenza A (H1N1) vaccine (Greenflu-S
Ⓡ, Korean 
Green Cross Corporation, Seoul, Korea). The patient was 
otherwise healthy. Routine laboratory tests were within 
normal ranges and serological tests for cytomegalovirus, 
Epstein- Barr virus, hepatitis A, hepatitis B, enterovirus 
pool, parovovirus B19, and Mycoplasma pneumoniae 
were negative. Screening for the novel influenza A virus 
was negative. Additionally, the result of polymerase chain 
reaction of nasopharyngeal secretion was negative for 
H1N1 virus. A skin-biopsy specimen showed intraepi-
dermal spongiosis and perivascular lymphocytic infiltra-
tions in the upper dermis (Fig. 2). The eruption sponta-
neously resolved after 3 weeks. In the present case, clin-
ical and histopathological features were consistent with 
GCS. 
The association between immunization and GCS has al-
ready been reported with hepatitis A, hepatitis B, Japanese 
B encephalitis, poliomyelitis, measles, rubella and mumps 
vaccination
1-5. Cambiaghi et al.
6 also reported a case of 
GCS in an adult after influenza virus vaccination. The ex-
act mechanism of GCS is still unclear, although a number 
of hypotheses have been proposed including a virus-in-
duced type IV cutaneous hypersensitivity, genetic factors 
or immunologic imbalance1.
Although the limited safety data of the pandemic H1N1 
virus vaccine generated, Plennevaux et al.
7 reported no 
new vaccine-related serious adverse reactions only for in-
jection-site reactions (erythema, swelling, induration or ec-
chymosis) and systemic reactions (headache, myalgia and 
malaise) up to about 50%, with no noticeable cutaneous 
reactions. To our knowledge, this is the first reported case 
of GCS following H1N1 vaccination.
Since immunization against influenza only rarely causes 
GCS, development of GCS is not a contraindication to 
completing the full course of injections. However, clini-
cians should be aware that GCS could be a possible ad-
verse reaction associated with the novel vaccine against 
the virus strain A/California/07/2009 H1N1. 
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Fig. 1. Papular eruption on both 
elbows.
Fig. 2. Epidermis shows spongiosis with hyperkeratosis and 
parakeratosis. Mixed perivascular infiltrate is present in the 
dermis (H&E, ×100).
Dermatol 2007;34:117-120.
5. Haug S, Schnopp C, Ring J, Fölster-Holst R, Abeck D. 
Gianotti-Crosti syndrome following immunization. Hautarzt 
2002;53:683-685.
6. Cambiaghi S, Scarabelli G, Pistritto G, Gelmetti C. Gianotti- 
Crosti syndrome in an adult after influenza virus vaccination. 
Dermatology 1995;191:340-341.
7. Plennevaux E, Sheldon E, Blatter M, Reeves-Hoché MK, 
Denis M. Immune response after a single vaccination against 
2009 influenza A H1N1 in USA: a preliminary report of two 
randomised controlled phase 2 trials. Lancet 2010;375:41- 
48.